Table 1 Review of reports on tumor infiltrating lymphocytes

HNSCC

100% (n = 40)

^c T11⁺, T4⁺ or T8⁺

Rare B1⁺ or Leu 7⁺

T8⁺ cell

N.T

[32]

89% of HPV⁺ cases (17/19)

56% to 64% in the rest;

136 cases totally

^c CD3⁺, CD8⁺, CD20⁺

CD3⁺ T cell

N.T

[30]

100% (n = 50)

^c CD20⁺ B cell

Peritumoral CD20⁺ cell

N.T

[33]

^c 98.8% (n = 85)

Not mentioned

Not mentioned

N.T

[34]

100% (n = 5)

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[39]

^b17.8% (8/45 total cases); 50% (8/16 xenografts)

^bCD20⁺ cell

partially with CD3⁺ cells

Not mentioned

8 EBV⁺ cases

[38]

Lung cancer

1/1

unknown

Not mentioned

N.T

[42]

93.75% (n = 32)

(Brain metastasis)

^c。CD3⁺ T cell, CD8⁺, FoxP3⁺

Not mentioned

N.T

[35]

16.2% (n = 155)

^c CD3⁺ T cell, CD20⁺ B cell

CD3⁺ cell, CD45⁺ cell, CD20⁺ cell

N.T

[52]

Brest cancer

29.2% (n = 788)

^c B cell, T cell

B cell

N.T

[36]

1/1

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[40]

1/1

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[42]

64.4% (n = 90) CD3⁺

24.4% (n = 90) CD20⁺

^c B cell, T cell

Not mentioned

N.T

[31]

Cervical and ovarian cancer

1/1

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[40]

2/2

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[42]

100% (n = 18)

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[39]

Gastrointestinal cancer

1/1

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[42]

Colorectal cancer

100% (n = 67)

^c 100% with CD4⁺ CD8⁺

53.7% with CD20⁺

Not mentioned

N.T

[37]

1/1

^a CD3⁺ T cell with CD8⁺ or CD25⁺

Not mentioned

N.T

[40]

2/2

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[42]

38.3% (n = 47)

^bCD45⁺ cells with CD20⁺

Not mentioned

12 EBV ⁺ cases

[5]

100% (n = 5)

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[39]

Pancreatic ductal adenocarcinomas

32.4% (n = 37)

^bCD45⁺ cells with CD20⁺

Not mentioned

4 EBV ⁺ cases

[5]

Urinary system cancer

100% (n = 9)

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[40]

1/1

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[42]

1/1

^a,c CD20⁺ B cell

Not mentioned

EBV ⁺

[4]

Melanoma

2/2

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[40]

100% (n = 9)

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[42]

100% (n = 196)

^a T lymphocyte

Not mentioned

N.T

[41]

Sarcoma

1/1

^a CD3⁺ T cell with CD8⁺ or CD25⁺

Not mentioned

N.T

[40]

100% (n = 10)

^a CD3⁺ T cell with CD4⁺ or CD8⁺

Not mentioned

N.T

[42]